News
)
9 March 2022
PharmaBoardroom interviews Gurutz Linazasoro, CEO of VIVEbiotech
PharmaBoardroom, the global platform for healthcare & life sciences executives, interviewed Gurutz Linazasoro, CEO of VIVEbiotech.
Read more)
18 February 2022
VIVEbiotech receives the “LH Duala Euskaraz” award
VIVEbiotech has been awarded with the “LH Duala Euskaraz” prize for promoting the use of Euskara, the language of the Basque Country, on a regular...
Read more)
2 February 2022
PharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022
PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it highlights VIVEbiotech as one of the ten Spanish...
Read more)
5 January 2022
Article on improving viral vector production in GEN
GEN recently interviewed our Business Development Director, Dr. Natalia Elizalde, with whom they spoke about improving the production of lentiviral vectors, vectors that VIVEbiotech develops...
Read more)
)
26 November 2021
Gurutz Linazasoro has been awarded a 2021 Korta Award
The CEO of VIVEbiotech, Gurutz Linazasoro, has received one of the four 2021 Korta Awards delivered this past Wednesday by the Lehendakari Iñigo Urkullu.
Read more)
28 October 2021
Successful participation of VIVEbiotech in five international meetings in the last half of the year
VIVEbiotech has participated very successfully in five international meetings since the summer.
Read more)
22 October 2021
Juan Carlos Ramírez, CSO/CTO of VIVEbiotech, forever in science and in our hearts
VIVEbiotech colleagues have lived a very painful week due to the death of our colleague and friend Juan Carlos Ramírez.
Read more)
28 July 2021
Video-report about VIVEbiotech in El Exportador
The digital magazine ‘El Exportador’, edited by ICEX Spain Exports and Investments -the Spanish Institute for Foreign Trade-, has published a video-report on VIVEbiotech as...
Read more7 July 2021
VIVEbiotech obtains the seal of a Company Committed to Youth Employment
This seal is a recognition to VIVEbiotech for its commitment to the Comprehensive Qualification and Employment Program.
Read moreDestacadas
)
28 September 2023
VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation
)
14 September 2023
The Medicine Maker publishes an opinion article after interviewing Natalia Elizalde
)
24 August 2023
)
14 August 2023
Contribution to an article defining the benefits of lentiviruses in BioPharm International
)
11 July 2023
)
4 June 2023